- Annual meeting and voting
- Buy side
- Careers
- Case studies
- Corporate governance
- Deals
- Disclosure & regulation
- Earnings calls
- Financial reporting
- IR TV
- IR websites
- People moves
- Roadshows
- Sell side
- Shareholder activism
- Shareholder targeting & ID
- Social media
- Sustainability
- Breaking news
- Comment
- International listings
- Special publications
Roche on the road
The pharmaceutical giant mixes up institutional and retail targeting while on the road in the US
| Tweet |
Nina Goworek, an IR officer for Roche, is on the road several days a month explaining the Swiss-based pharmaceutical giant to US institutional investors in money centers across North America. But, at the same time, the IR effort is not overlooking individual investors.
‘As times are getting tougher, a lot ...
Register now to read the rest of this article! Registration is free and you will be able to read five articles every month.
Become a subscriber for unlimited access.
Read More About Topics
More on sectors in this article
More on companies in this article
About Ipreo
Built on a legacy of experience and a thorough understanding of the capital markets, Ipreo provides sophisticated market intelligence, robust technology, and superior customer service to help our clients run better investor relations programs.
www.ipreo.com
Special reports from our partners
Ipreo: Global Equity Assets Report - Q4 2011- Dix & Eaton: Are you ready for the public?
- OTCQX International: Attractive US Trading Platform for Non-US Blue Chip Companies
- MessageBank: OpenExchange desktop video conferencing network
Weekly IR poll
Ask the Expert on the following topic
More Articles Like this
Featured Articles
Print magazine
All the articles from the May edition of
IR magazine
Technology
Walmart launches a new IR app plus
a video-heavy annual report
IR societies
How the Netherlands’ IR association
has promoted IR for 20 years
